Melanin production inhibitor
Abstract
Disclosed is a melanin production inhibitor which has an excellent inhibitory activity on the production of melanin and is highly safe. The melanin production inhibitor is represented by general formula (1) (excluding clotrimazole) and/or a pharmacologically acceptable salt thereof. In the formula, A1, A2 and A3 are independently selected from a hydrogen atom, an aryl group which may have a substituent, and an aromatic heterocyclic group which may have a substituent. At least one of A1, A2 and A3 is selected from the aryl group and the aromatic heterocyclic group, the total number of carbon atoms contained in A1, A2 and A3 is 6 to 50 and, when at least two of A1, A2 and A3 represent the aryl groups or the aromatic heterocyclic groups, the adjacent two aryl or aromatic heterocyclic groups may be bound to each other via an alkyl chain or an alkenyl chain to form a ring; m represents an integer of 0 to 2; X represents a hetero atom, a hydrogen atom, or a carbon atom; R1 and R2 are independently selected from a hydrogen atom and an oxo group. When one of R1 and R2 is an oxo group, the other is not present. R3 is selected from a hydrogen atom, and a C 1-8 hydrocarbon group in which one or some of hydrogen atoms or carbon atoms may be substituted by a hetero atom or hetero atoms. The number of R3's present in the compound corresponds to X and, when two or more R3's are present, the R3's are independently present and the adjacent two R3's may be bound to each other to form, together with X, a ring, and the terminal of R3 may be bound to a carbon atom to which A1, A2 and A3 are bound, thereby forming a ring.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for inhibiting melanin production, comprising administering to a subject requiring melanin production inhibition a compound of the following general formula (1), excluding clotrimazole, and/or a pharmacologically acceptable salt thereof:
where A1, A2, and A3 are each independently selected from the group consisting of a hydrogen atom, an aryl group which may have a substituent, and an aromatic heterocyclic group which may have a substituent, provided that at least one of A1, A2, and A3 is selected from the group consisting of the aryl group and the aromatic heterocyclic group, and a total number of carbon atoms included in A1, A2, and A3 is 6 to 50;
when two or more of A1, A2, and A3 each are the aryl or the aromatic heterocyclic groups, the adjacent two aryl groups or aromatic heterocyclic groups may be bound to each other via an alkyl chain or an alkenyl chain to further form a ring;
m is an integer of 0 to 2;
X is a hetero atom, a hydrogen atom, or a carbon atom;
R1 and R2 are each independently selected from the group consisting of a hydrogen atom and oxo, provided that, when one of R1 and R2 is the oxo, the other is absent;
R3 is selected from the group consisting of a hydrogen atom, and a hydrocarbon group having 1 to 8 carbon atoms, in which part of hydrogen atoms or carbon atoms may be substituted by a hetero atom, and a number of R3's corresponds to X;
provided that, when two or more R3's are present, the R3's are each independent of each other, and when two or more R3's are present, the adjacent two R3's may be bound to each other to form a ring together with X; and
a terminal of R3 may be bound to a carbon atom to which A1, A2, and A3 are bound, thereby forming a ring.
2 . The method according to claim 1 , wherein X is a hetero atom or a carbon atom.
3 . The method according to claim 2 , wherein the aryl group is selected from the group consisting of phenyl, biphenyl, and naphthyl, and the aromatic heterocyclic group is selected from the group consisting of pyridyl and quinolyl.
4 . The method according to claim 2 , wherein X is a nitrogen atom, an oxygen atom, or a carbon atom.
5 . The method according to claim 2 , wherein m is 0.
6 . The method according to claim 2 , wherein —X—R3 is general formula (3):
where X1 is a carbon atom or a nitrogen atom;
R7 is a hydrocarbon ring group which has 3 to 8 carbon atoms and may have a substituent; and
R8 is a hydrogen atom, and a number of R8's corresponds to X1.
7 . The method according to claim 2 , wherein —X—R3 is general formula (4):
where X2 is a nitrogen atom or an oxygen atom;
n is an integer of 0 to 5;
Y is selected from the group consisting of hydroxyl, amino, and an alkyloxy having 1 to 6 carbon atoms;
R9 is selected from the group consisting of a hydrogen atom, hydroxyl, and a hydroxyalkyl having 1 to 6 carbon atoms when X2 is a nitrogen atom, and R9 is absent when X2 is an oxygen atom; and
R10, R11, and R12 are each independently selected from the group consisting of a hydrogen atom, hydroxyl, oxo, and a hydroxyalkyl having 1 to 5 carbon atoms, provided that, when one of R10 and R11 is the oxo, the other is absent.
8 . The method according to claim 7 , wherein the compound is general formula (6):
where A4, A5, and A6 are each independently selected from the group consisting of phenyl and pyridyl each of which may be substituted by methyl, methoxy, or hydroxyl;
X2 is a nitrogen atom or an oxygen atom;
Y1 is hydroxyl or amino;
R15 is selected from the group consisting of a hydrogen atom, hydroxyl, and a hydroxyalkyl having 1 to 3 carbon atoms when X2 is a nitrogen atom, and R15 is absent when X2 is an oxygen atom; and
R16 is selected from the group consisting of a hydrogen atom, hydroxyl, and a hydroxyalkyl having 1 to 3 carbon atoms.
9 . The method according to claim 8 , wherein the compound is selected from the group consisting of 2-(triphenylmethyloxy)ethanol (Compound 2), 2-(triphenylmethylamino)ethanol (Compound 3), and 2-(triphenylmethyloxy)ethylamine (Compound 4).
10 . The method according to claim 1 , wherein the compound is selected from the group consisting of triphenylmethylamine, triphenylmethanol, triphenylmethane, and aminodiphenylmethane.
11 . The method according to claim 1 , wherein the compound of general formula (1) is free of an imidazole skeleton.
12 . The method according to claim 1 , wherein the compound has a MIC 80 of 10 times or more that of clotrimazole.
13 . The method according to claim 1 , wherein the compound is free of an effect of inhibiting expression of tyrosinase protein at a minimum effective dose for melanin production inhibition.Join the waitlist — get patent alerts
Track US2015328107A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.